Literature DB >> 28786897

Cardiovascular Manifestations of Pheochromocytoma.

Yu Wei Gu1, Jennifer Poste, Mehta Kunal, Monica Schwarcz, Irene Weiss.   

Abstract

Pheochromocytomas are rare endocrine tumors that can have a significant impact on a variety of organ systems, including the cardiovascular system. Although the pathophysiology is not completely understood, pheochromocytomas exert their effects through high levels of catecholamines, mainly epinephrine and norepinephrine, which stimulate adrenergic receptors, including those within the cardiovascular system. Although the most common cardiovascular manifestation is hypertension, patients with pheochromocytoma can present with arrhythmia, hypotension, shock, myocardial ischemia, cardiomyopathy, aortic dissection, and peripheral ischemia. The medical management of the cardiovascular effects of pheochromocytoma is via blockade of adrenergic receptors, usually through the use of alpha blockers, with the addition of beta blockers if needed. However, only surgical resection of the pheochromocytoma is potentially curative, and this tumor requires unique management perioperatively. Because of the variability of presentation and the significant morbidity and mortality of patients with an undiagnosed pheochromocytoma, this entity should not be overlooked in the evaluation of patients with a wide variety of cardiovascular disorders.

Entities:  

Year:  2017        PMID: 28786897     DOI: 10.1097/CRD.0000000000000141

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  12 in total

Review 1.  Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings.

Authors:  Guido Grassi; Fosca Quarti Trevano; Raffaella Dell'Oro; Gino Seravalle; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

2.  Effects of pretreatment with terazosin and valsartan on intraoperative haemodynamics in patients with phaeochromocytoma.

Authors:  Qingrong Ji; Feng Li; Xianzhao Zhang; Yuqiang Wang; Cunfei Liu; Ying Chang
Journal:  Eur J Hosp Pharm       Date:  2020-09-07

3.  3T MRI evaluation of regional catecholamine-producing tumor-induced myocardial injury.

Authors:  Satoshi Higuchi; Hideki Ota; Takuya Ueda; Yuta Tezuka; Kei Omata; Yoshikiyo Ono; Ryo Morimoto; Masataka Kudo; Fumitoshi Satoh; Kei Takase
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

4.  ST-Segment Elevation Myocardial Infarction Related to Potential Spontaneous Coronary Thrombosis in Pheochromocytoma Crisis.

Authors:  Fei Chen; Mingxia Zheng; Xi Li; Yong Peng; Mao Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-18       Impact factor: 5.555

5.  Unexpected adrenal pheochromocytoma associated with a generalized tonic-clonic seizure in a prepubertal boy: A case report.

Authors:  Zlatan Zvizdic; Mirsad Selimovic; Amira Mesic; Dusko Anic; Verica Misanovic; Faruk Skenderi; Semir Vranic
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

6.  Catecholamine-induced cardiomyopathy improvement after para-aortic paraganglioma resection: a case report.

Authors:  Maryam Ranjbar; Ahmad Amin; Ziae Totonchi; Zahra Ghaemmaghami; Zahra Jalilian; Mahshid Hesami; Nader Givtaj; Amir Nasser Jadbabaei; Iman Divanbeigi; Mohammad Mohsen Mazloomfard
Journal:  ESC Heart Fail       Date:  2021-12-29

7.  When Zebras Collide: A Case of Synchronous Wolff-Parkinson-White Syndrome and Pheochromocytoma.

Authors:  Kaiwen Zhu; Stacey Solin; Madeleine S Deming
Journal:  Am J Case Rep       Date:  2021-12-06

8.  Research on the Damage of Adrenal Pheochromocytoma to Patients' Cardiovascular Vessels and Its Correlation with Hypertension.

Authors:  Xiaohui Wang; Qiuping Zhao; Haiqiang Sang; Jiajia Dong; Minfu Bai
Journal:  J Oncol       Date:  2022-02-11       Impact factor: 4.375

9.  Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center.

Authors:  Henrik Falhammar; Magnus Kjellman; Jan Calissendorff
Journal:  Endocr Connect       Date:  2017-12-07       Impact factor: 3.335

Review 10.  Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors.

Authors:  Rodrigo Toledo; Camilo Jimenez
Journal:  F1000Res       Date:  2018-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.